Fluorescent imaging during stomach or esophagus surgery
Part of Cancer, Digestive system clinical trials.
This study tests whether a special fluorescent camera during surgery can help surgeons better operate on resectable (removable) stomach or esophagus cancer. It may help improve how surgery is guided, with the goal of safer and more accurate tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- Your stomach or esophagus cancer is confirmed by biopsy and is planned for surgery, with no distant metastases.
- You can safely receive anesthesia (sleep for surgery) and you’re fit for stomach and/or esophagus surgery.
- You can understand the study and sign written consent.
- You are covered by the French social security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
This trial tests whether an “ICG” dye and special camera can help surgeons see cancer more clearly during surgery for advanced stomach cancer. It may help improve how safely and accurately surgeons remove the tumor and nearby lymph nodes.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.